相关实验视频
Updated: Jun 27, 2026

06:09
An In Ovo Model for Testing Insulin-mimetic Compounds
Published on: April 23, 2018
非胰岛素瘤的分子分类和特征:准备好在临床实践中首次使用吗?
1Pathology Department, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China.
International journal of surgical pathology
|March 29, 2025
概括
这项研究审查了基因组,表观基因组,转录基因组和蛋白质组数据如何用于分类罕见的胰腺瘤非胰岛素瘤. 了解这些分子亚型是预测患者预后和复发风险的关键.
科学领域:
- 在瘤学瘤学.
- 遗传学 是一个遗传学.
- 分子生物学分子生物学
背景情况:
- 胰腺神经内分泌瘤 (PNET) 是罕见且多样化的,分为功能性或非功能性.
- 非胰岛素瘤PNETs表现出不同的分子形状,包括与预后不佳和端粒替代延长相关的ATRX/DAXX突变.
- 副本数的变化也是非胰岛素瘤复发风险的预后指标.
研究的目的:
- 要总结采用多组学方法进行非胰岛素瘤分子分类的研究.
- 根据分子数据,突出非胰岛素瘤中的异质性.
- 为了将分子亚型与患者的预后和复发相关联.
主要方法:
- 使用基因组,表观基因组,转录基因组和蛋白质组数据发表的研究的审查.
- 对非胰岛素瘤分子类型的多组学数据的分析.
- 综合表观遗传,代谢和蛋白质组数据.
主要成果:
- 非胰岛素瘤亚型之间存在显著的分子表达差异.
- 不同的分子组显示出不同的患者预后.
- 基因组和表观基因组数据对于分类非胰岛素瘤至关重要.
结论:
- 多组学方法提供了非胰岛素瘤的详细分子分类.
- 分子类型识别对于理解疾病异质性和预后至关重要.
- 对这些亚型的进一步研究可以改善非胰岛素瘤患者的治疗结果.
相关概念视频
Diabetes Mellitus: Overview and Type I Subtype
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Insulin: The Receptor and Signaling Pathways
Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but this inhibition is released...
Insulin: Biosynthesis, Chemistry, and Preparation
The endoplasmic reticulum (ER) of pancreatic β-cells synthesizes preproinsulin, which consists of a signal peptide, A and B chains, and a C-peptide. Preproinsulin is then cleaved and folded into proinsulin, which translocates to the Golgi apparatus for sorting and packaging into secretory granules. In these granules, enzymatic clipping generates insulin and C-peptide.
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment primarily uses...
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment primarily uses...
Type I Diabetes III: Clinical Manifestations
Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...
Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...

